NCT05353179 - Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions

Granulomatosis With PolyangiitisHemophagocytic Syndrome

Interventions

DRUG

Meperizumab injection

Meperizumab injection is a humanized monoclonal antibody of IgG1 injection

DRUG

NUCALA®

NUCALA® is a humanized monoclonal antibody of IgG1 injection

Trial Locations (1)

Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun